<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03458754</url>
  </required_header>
  <id_info>
    <org_study_id>Gazi University 9</org_study_id>
    <nct_id>NCT03458754</nct_id>
  </id_info>
  <brief_title>Maximal Exercise Capacity, Physical Activity and Respiratory Muscle Strength in Peripheral Artery Disease</brief_title>
  <official_title>Assessment of Exercise Capacity, Physical Activity, Pulmonary Function, Peripheric and Respiratory Muscle Strength, Respiratory Muscle Endurance in Patient With Peripheral Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the study is to evaluate the maximal and submaximal exercise capacity in
      patients with peripheral artery disease (PAD). The secondary aim of the study is assessment
      of physical activity level, respiratory function, peripheral and respiratory muscle strength,
      respiratory muscle endurance, depression, quality of life, intermittent claudication and
      cardiovascular risk factors in patients with PAD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peripheral artery disease is characterized by reduced exercise capacity, physical activity
      level and intermittent claudication. The number of studies investigating maximal and
      submaximal exercise capacity and physical activity level in PAD is limited. There is also no
      study investigated pulmonary functions, respiratory muscle strength and endurance in this
      patient population. According to the sample size analysis 15 patients and 15 healthy
      individuals with similar demographic characteristics will be included the study. Patients and
      healthy individuals will be selected according to predetermined inclusion and exclusion
      criteria. The assessments will be completed in two days.Maximal exercise capacity will be
      assessed using cardiopulmonary exercise testing (CPET), functional exercise capacity using
      six minute stepper test, physical activity using multi-sensor activity monitor, pulmonary
      function using spirometry, respiratory muscle strength using mouth pressure device,
      peripheral muscle strength using hand held dynamometer, respiratory muscle endurance using
      incremental threshold loading test, depression using Beck depression inventory (Turkish
      version), life quality using SF-36 Health Survey (Turkish version), intermittent claudication
      using Walking Impairment Questionnaire (Turkish version)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal exercise capacity</measure>
    <time_frame>First day</time_frame>
    <description>Cardiopulmonary exercise testing (Oxygen consumption measurement during test)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional exercise capacity</measure>
    <time_frame>Second day</time_frame>
    <description>Six minute stepper test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>Second day</time_frame>
    <description>Multi sensor activity monitor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function</measure>
    <time_frame>First day</time_frame>
    <description>Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory muscle strength</measure>
    <time_frame>First day</time_frame>
    <description>Mouth pressure device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral muscle strength</measure>
    <time_frame>Second day</time_frame>
    <description>Hand held dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory muscle endurance</measure>
    <time_frame>Second day</time_frame>
    <description>Incremental threshold loading test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>Second day</time_frame>
    <description>Beck depression inventory (Turkish version)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life quality</measure>
    <time_frame>Second day</time_frame>
    <description>SF-36 Health Survey (Turkish version)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intermittent claudication</measure>
    <time_frame>Second day</time_frame>
    <description>Walking Impairment Questionnaire (Turkish version)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Maximal exercise capacity will be assessed using cardiopulmonary exercise testing (CPET), functional exercise capacity using six minute stepper test, physical activity using multi-sensor activity monitor, pulmonary function using spirometry, respiratory muscle strength using mouth pressure device, peripheral muscle strength using hand held dynamometer, respiratory muscle endurance using incremental threshold loading test, depression using Beck depression inventory (Turkish version), life quality using SF-36 Health Survey (Turkish version), intermittent claudication using Walking Impairment Questionnaire (Turkish version)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>Maximal exercise capacity will be assessed using cardiopulmonary exercise testing (CPET), functional exercise capacity using six minute stepper test, physical activity using multi-sensor activity monitor, pulmonary function using spirometry, respiratory muscle strength using mouth pressure device, peripheral muscle strength using hand held dynamometer, respiratory muscle endurance using incremental threshold loading test, depression using Beck depression inventory (Turkish version), life quality using SF-36 Health Survey (Turkish version), intermittent claudication using Walking Impairment Questionnaire (Turkish version)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        At least 15 patients with PAD will be included in patients group and 15 healthy individuals
        will be included in control group
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients;

          -  Diagnosed with peripheral artery disease

          -  Ankle brachial index (ABI)≤ 1,5 or calcified vessel response

          -  Clinically stable and under standard medication patients will be included

        Exclusion Criteria:

        Patients with;

          -  Ischemic amputation

          -  Any pulmonary disease

          -  Unstable coronary artery disease

          -  Orthopedic and neurological problems

          -  Acute infection

          -  Myocardial infarction or major surgery in the last 3 months will be excluded

        Healthy controls: Ages 18-80 years will be included

          -  With any diagnosed disease and smoking more than 10 packsyears will be excluded
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>İnci Hazal Ayas, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Meral Boşnak Güçlü, Assoc. Prof</last_name>
    <role>Study Director</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Burcu Camcıoğlu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dilek Erer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abdullah Özer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meral Boşnak Güçlü, Assoc. Prof</last_name>
    <phone>03122162612</phone>
    <email>bosnakmeral@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>İnci Hazal Ayas, MSc</last_name>
    <phone>03122162612</phone>
    <email>inciayass@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gazi University</name>
      <address>
        <city>Ankara</city>
        <zip>06500</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meral Boşnak-Güçlü, PhD</last_name>
      <phone>+903122162612</phone>
      <email>bosnakmeral@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>İnci Hazal Ayas, Pt</last_name>
      <phone>+903122162612</phone>
      <email>inciayass@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation</name>
      <address>
        <city>Yenimahalle</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>, Pt</last_name>
      <phone>+903122162612</phone>
    </contact>
    <contact_backup>
      <last_name>, Phd</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Leeper NJ, Myers J, Zhou M, Nead KT, Syed A, Kojima Y, Caceres RD, Cooke JP. Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. J Vasc Surg. 2013 Mar;57(3):728-33. doi: 10.1016/j.jvs.2012.07.051. Epub 2012 Oct 6.</citation>
    <PMID>23044259</PMID>
  </reference>
  <reference>
    <citation>Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation. 2011 Jul 5;124(1):17-23. doi: 10.1161/CIRCULATIONAHA.110.003954. Epub 2011 Jun 20.</citation>
    <PMID>21690489</PMID>
  </reference>
  <reference>
    <citation>Nordanstig J, Broeren M, Hensäter M, Perlander A, Osterberg K, Jivegård L. Six-minute walk test closely correlates to &quot;real-life&quot; outdoor walking capacity and quality of life in patients with intermittent claudication. J Vasc Surg. 2014 Aug;60(2):404-9. doi: 10.1016/j.jvs.2014.03.003. Epub 2014 Mar 29.</citation>
    <PMID>24690492</PMID>
  </reference>
  <reference>
    <citation>Colas-Ribas C, Signolet I, Henni S, Feuillloy M, Gagnadoux F, Abraham P. High prevalence of known and unknown pulmonary diseases in patients with claudication during exercise oximetry: A retrospective analysis. Medicine (Baltimore). 2016 Oct;95(40):e4888.</citation>
    <PMID>27749546</PMID>
  </reference>
  <reference>
    <citation>Sieminski DJ, Gardner AW. The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med. 1997 Nov;2(4):286-91.</citation>
    <PMID>9575600</PMID>
  </reference>
  <reference>
    <citation>Gardner AW, Montgomery PS, Scott KJ, Blevins SM, Afaq A, Nael R. Association between daily ambulatory activity patterns and exercise performance in patients with intermittent claudication. J Vasc Surg. 2008 Nov;48(5):1238-44. doi: 10.1016/j.jvs.2008.06.062. Epub 2008 Sep 4.</citation>
    <PMID>18771878</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2018</study_first_submitted>
  <study_first_submitted_qc>March 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>March 9, 2018</last_update_submitted>
  <last_update_submitted_qc>March 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Meral Boşnak Güçlü</investigator_full_name>
    <investigator_title>Assoc. Prof</investigator_title>
  </responsible_party>
  <keyword>Peripheral Arterial Disease</keyword>
  <keyword>Exercise capacity</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Respiratory muscle strength</keyword>
  <keyword>Peripheric muscle strength</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

